论文部分内容阅读
目的探讨膀胱炎性肌纤维母细胞瘤的临床、病理、组织生化特征和诊治方法及预后。方法回顾性分析1例肌纤维母细胞瘤患者的诊治资料,并结合文献进行探讨。结果患者术后恢复良好,7 d拆线,临床症状消失,每3~6个月复查膀胱镜,随访3年,未见病灶复发或扩散,患者无瘤生存。结论膀胱炎性肌纤维母细胞瘤为低度恶性肿瘤,罕见。确诊依据病理学检查,治疗原则以切除肿瘤、保留膀胱功能为主,行膀胱部分切除或经尿道膀胱肿瘤电切术(TURBT术)。
Objective To investigate the clinical, pathological, biochemical characteristics, diagnosis and treatment of bladder inflammatory myofibroblastic tumor and its prognosis. Methods A retrospective analysis of one case of myofibroblastic tumor patients with diagnosis and treatment data, combined with the literature to explore. Results The patient recovered well after operation. On the 7th day, the clinical symptoms disappeared. The cystoscopy was reviewed every 3 to 6 months. The patients were followed up for 3 years. No recurrence or spread of the lesions occurred in the patients. Conclusions Bladder inflammatory myoblastoma is a rare malignancy. Diagnosis based on pathological examination, the principle of treatment to remove the tumor, retain the main bladder function, partial bladder resection or transurethral resection of the bladder tumor (TURBT).